In a report released today, Matt Miksic from Barclays maintained a Buy rating on Medtronic (MDT – Research Report), with a price target of $109.00. The company’s shares closed yesterday at $91.20.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medtronic (MDT – Research Report), Biohaven Ltd. (BHVN – Research Report) and Arvinas Holding Company (ARVN ...
The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...
The Simulus ® Adjustable Annuloplasty Ring and Band are fully flexible and enable finite adjustments. Based on preference and patient need, surgeons can choose between the Simulus Adjustable ...
Edwards Lifesciences beats profit estimate on strength in heart devices February 11, 2025 Medtronic will appoint Renault's finance chief Thierry Pieton as its chief financial officer effective ...
Medtronic SureScan technical manual. † St. Jude MRI procedure information. ‡ Biotronik ProMRI manual. § Passive leads available as of January 2012. ¶ Heart Rhythm 2010; 7:750–754[20 ...
Passports with 'X' sex markers will be valid until they expire or are renewed, State Department says
The State Department issued new guidance on passports with “X” sex markers and applications that request to change a passport sex marker, according to a memo reviewed by NBC News. The new ...
Looking to learn what you need to know about the latest new products from XXIO? These handy thumbnails will keep you up to date on the company's new releases across all club and ball catetgories ...
Virtually all pacemakers are implanted under a local anaesthetic nowadays. An hour before the procedure, the patient will be given a pre-med Valium tablet. Once in the X-ray room - which is where ...
Ray Parlour says Alexander Isak has ‘got to be’ considered the ‘dream signing’ for Arsenal this summer, likening the striker to club legend Thierry Henry. Isak, 25, has established himself ...
Relatively weak magnets in consumer products have always posed some risk, usually very low, to the function of pacemakers and implantable cardioverter-defibrillators (ICDs). However, stronger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback